“Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity”, JOC, vol. 24, no. 3s, pp. 812–830, Oct. 2025, doi: 10.64149/J.Carcinog.24.3s.812-830.